Delta CleanTech Inc. (DELT.CN)
CAD 0.03
(0.0%)
CAD 0.03
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 1.03 Million | 1.41 Million | 375 Thousand | - |
| Cost of Revenue | 388.02 Thousand | 420.87 Thousand | 90.06 Thousand | - |
| Gross Profit | 644.05 Thousand | 992.1 Thousand | 284.93 Thousand | - |
| Operating Expenses | 3.52 Million | 3.83 Million | 3.92 Million | - |
| Selling, General and Administrative Expenses | 2.46 Million | 3.51 Million | 3.64 Million | - |
| Research and Development Expenses | 381.48 Thousand | 501.85 Thousand | 988.4 Thousand | - |
| Other Expenses | 684.01 Thousand | -185.35 Thousand | -706.79 Thousand | - |
| Cost and Expenses | 3.91 Million | 4.25 Million | 4.01 Million | - |
| Operating Income | -2.88 Million | -2.83 Million | -3.64 Million | - |
| Interest Expense | 7945.00 | 909.00 | 2074.00 | - |
| Income Tax Expense | - | -21.97 Thousand | 2074.00 | - |
| Earnings before Tax | -2.82 Million | -2.79 Million | -4.25 Million | - |
| Net Income | -2.76 Million | -2.77 Million | -4.26 Million | - |
| Earnings Per Share Basic | -0.04 | -0.05 | -0.07 | - |
| Earnings Per Share Diluted | -0.04 | -0.05 | -0.07 | - |
| Weighted Average Shares Outstanding | 64.53 Million | 58.77 Million | 58.52 Million | 58.52 Million |
| Weighted Average Shares Outstanding (Diluted) | 64.53 Million | 58.77 Million | 58.52 Million | 58.52 Million |
| Gross Margin | 0.62 | 0.70 | 0.76 | - |
| EBIT Margin | -2.42 | -1.77 | -8.92 | - |
| Profit Margin | -2.68 | -1.96 | -11.36 | - |
| EBITDA | -2.49 Million | -2.48 Million | -3.97 Million | - |
| Earnings Before Tax Margin | -2.79 | -2.01 | -9.71 | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 14.6 Thousand | 15.86 Thousand | 126.74 Thousand | 1.03 Million | 230.07 Thousand | 209.7 Thousand |
| Cost of Revenue | 362.99 Thousand | 325.92 Thousand | 419.01 Thousand | 1.63 Million | 17.03 Thousand | 106.96 Thousand |
| Gross Profit | -348.38 Thousand | -310.06 Thousand | -292.26 Thousand | -603.53 Thousand | 213.04 Thousand | 102.74 Thousand |
| Operating Expenses | 346.72 Thousand | 328.7 Thousand | 396.12 Thousand | 1.91 Million | 583.82 Thousand | 929.44 Thousand |
| Selling, General and Administrative Expenses | 346.72 Thousand | 328.7 Thousand | 396.12 Thousand | - | 504.16 Thousand | 562.72 Thousand |
| Research and Development Expenses | 64.83 Thousand | - | - | - | - | 286.95 Thousand |
| Other Expenses | 82.04 Thousand | - | - | - | - | - |
| Cost and Expenses | 709.71 Thousand | 654.62 Thousand | 815.14 Thousand | 3.55 Million | 600.86 Thousand | 1.03 Million |
| Operating Income | -695.11 Thousand | -638.77 Thousand | -688.4 Thousand | -2.51 Million | -235.03 Thousand | -802.98 Thousand |
| Interest Expense | 1419.00 | 1633.00 | 2020.00 | 7945.00 | 2187.00 | 1964.00 |
| Income Tax Expense | -42.86 Thousand | -16.52 Thousand | -3387.00 | -51.56 Thousand | 98.87 Thousand | -101.25 Thousand |
| Earnings before Tax | -762.2 Thousand | -641.2 Thousand | -1 Million | -2.82 Million | -513.17 Thousand | -1.08 Million |
| Net Income | -719.34 Thousand | 641.2 Thousand | -1 Million | -2.76 Million | -609.86 Thousand | -982.73 Thousand |
| Earnings Per Share Basic | -0.01 | -0.01 | -0.02 | - | -0.01 | -0.02 |
| Earnings Per Share Diluted | -0.01 | -0.01 | -0.02 | - | -0.01 | -0.02 |
| Weighted Average Shares Outstanding | 102.76 Million | 90.83 Million | 64.53 Million | 64.53 Million | 62.92 Million | 61.07 Million |
| Weighted Average Shares Outstanding (Diluted) | 102.76 Million | 90.83 Million | 64.53 Million | 64.53 Million | 62.92 Million | 61.07 Million |
| Gross Margin | -23.85 | -19.55 | -2.31 | -0.58 | 0.93 | 0.49 |
| EBIT Margin | -41.96 | -35.24 | -4.80 | - | -1.22 | -3.49 |
| Profit Margin | -49.24 | -39.39 | -7.91 | -2.68 | -2.65 | -4.69 |
| EBITDA | -613.06 Thousand | -558.9 Thousand | -608.98 Thousand | - | -279.61 Thousand | -732.86 Thousand |
| Earnings Before Tax Margin | -47.58 | -40.28 | -5.43 | -2.44 | -1.02 | -3.83 |
7709
IRIS
7438
ALRGR
EXPLEOSOL
SOFW